by Indigo | Jun 11, 2025 | 2025, News
We are proud to announce that Indigo Diabetes NV has been selected as one of just 65 startups to join the prestigious 2025 MedTech Innovator Accelerator Cohort. Chosen from a pool of nearly 1,500 global applicants, this places us among the top 4% of emerging medtech...
by Indigo | Apr 15, 2025 | 2025, News
We are proud to announce that Indigo has been recognized as a ‘Key Innovator’ by the European Commission’s Innovation Radar for its groundbreaking work on the Multi-Metabolite Sensor, developed within the MuSiC4Diabetes project. This recognition...
by Indigo | Mar 20, 2025 | 2025, News
Indigo Diabetes NV is proud to announce the successful completion of the SHINE Study, a six-month feasibility trial of our implantable continuous multi-metabolite monitor — designed to measure glucose, ketone, and lactate concentrations in real time. By eliminating...
by Indigo | Oct 4, 2024 | 2024, News
Indigo is pleased to announce the successful completion of its annual EN ISO 13485:2016 surveillance audit, conducted by TÜV SÜD, reaffirming its certification for the design and development of biomarker sensing devices and services. This certification emphasizes the...
by Indigo | May 29, 2024 | 2024, News
Indigo has been granted U.S. Patent No. 11,992,310 for its personal health monitoring system. This revolutionary technology is designed to enhance continuous health monitoring by using a minimally invasive insertable sensor to track critical parameters like glucose...
